This inventor holds 3 USPTO granted patents and 1 published patent application, plus 1 CIPO patent. Top assignees: Medinet Co., Ltd., Shionogi Company Limited, Other. Active years: 2003-2020.
Location History:
- Osaka, JP (2003 - 2004)
- Tokyo, JP (2020)
Company Filing History:
1 out of 9 
1 out of 1,001 
2 out of 834,411 Years Active: 2003-2020
Title: Ryuji Maekawa: Innovator in Antibody Detection and Anticancer Research
Introduction
Ryuji Maekawa is a prominent inventor based in Osaka, Japan. He has made significant contributions to the fields of antibody detection and anticancer research. With a total of three patents to his name, Maekawa's work is recognized for its innovative approaches and practical applications.
Latest Patents
One of Maekawa's latest patents is a method for producing a reagent for antibody detection and its use. This invention provides an efficient method for producing a reagent that specifically binds with insoluble antigen proteins present in liquid samples. The method allows for the efficient solubilization and recovery of antigen proteins using a cationizing agent. Compared to conventional methods, this approach enables the production of reagents that can detect antibodies bound to multiple antigen protein molecules in a carrier. Another notable patent involves oxadiazole derivatives that exhibit anticancer effects, showcasing his commitment to advancing medical research.
Career Highlights
Throughout his career, Ryuji Maekawa has worked with various companies, including Shionogi & Company Limited. His innovative work has positioned him as a key figure in the development of new technologies in the medical field.
Collaborations
Maekawa has collaborated with notable colleagues such as Takayuki Yoshioka and Fumihiko Watanabe. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Ryuji Maekawa's contributions to antibody detection and anticancer research highlight his innovative spirit and dedication to improving medical technologies. His patents reflect a commitment to advancing scientific knowledge and practical applications in healthcare.